Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenet Healthcare

121.74
-2.5050-2.02%
Volume:388.21K
Turnover:47.69M
Market Cap:11.49B
PE:3.72
High:125.85
Open:125.78
Low:120.85
Close:124.24
Loading ...

Barclays Sticks to Their Buy Rating for Tenet Healthcare (THC)

TIPRANKS
·
13 Feb

Q4 2024 Tenet Healthcare Corp Earnings Call

Thomson Reuters StreetEvents
·
13 Feb

Tenet Healthcare Corp (THC) Q4 2024 Earnings Call Highlights: Strong Growth and Strategic Moves

GuruFocus.com
·
13 Feb

Tenet Healthcare Corp : Leerink Partners Cuts Target Price to $185 From $202

THOMSON REUTERS
·
13 Feb

Stock Track | Tenet Healthcare Plummets 6.86% as Revenue Falls Short, FY2025 Outlook Disappoints

Stock Track
·
12 Feb

Tenet Healthcare Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Feb

Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics

Zacks
·
12 Feb

Tenet Healthcare (THC) Surpasses Q4 Earnings Estimates

Zacks
·
12 Feb

Tenet Healthcare 4Q Revenue Slides After Divestitures

Dow Jones
·
12 Feb

Tenet Healthcare Q4 Adjused Earnings Increase, Revenue Decreases; 2025 Outlook Issued

MT Newswires Live
·
12 Feb

Tenet: Q4 Earnings Snapshot

Associated Press Finance
·
12 Feb

Tenet Healthcare Forecasts FY2025 Net Operating Revenues Of $20.6B-$21B Versus Consensus Of $21.28B, With Adjusted EPS Of $11.74-$12.84 Versus Consensus Of $11.53

Benzinga
·
12 Feb

Tenet Healthcare Outlook FY Net Operating Revenue USD 20,600-21,000 Million

THOMSON REUTERS
·
12 Feb

Tenet Healthcare Q4 Adjusted EPS USD 3.44 VS. Ibes Estimate USD 2.97

THOMSON REUTERS
·
12 Feb

Can Tenet Healthcare Navigate Through Lower Revenues in Q4?

Zacks
·
12 Feb

Tenet Healthcare (THC) Reports Q4: Everything You Need To Know Ahead Of Earnings

StockStory
·
11 Feb

Investing in Tenet Healthcare (NYSE:THC) five years ago would have delivered you a 321% gain

Simply Wall St.
·
09 Feb

Countdown to Tenet (THC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Zacks
·
07 Feb

Tenet Healthcare Shares Hit Session Low, Last Down 3.1% at $140.51

THOMSON REUTERS
·
07 Feb

CV Sciences unveils Aura Collection’s THC Fizz Tablets

TIPRANKS
·
05 Feb